Modeling COVID-19 vaccine efficacy and coverage towards herd-immunity in the Basque Country, Spain

Nico Stollenwerk,Javier Mar,Joseba Bidaurrazaga Van-Dierdonck,Oliver Ibarrondo,Carlo Estadilla,Maíra Aguiar
DOI: https://doi.org/10.1101/2021.07.12.21260390
2021-07-15
Abstract:Abstract Vaccines have measurable efficacies, obtained first from vaccine trials. However, vaccine efficacy is not a static measure upon licensing, and the long term population studies are very important to evaluate vaccine performance and impact. COVID-19 vaccines were developed in record time and although the extent of sterilizing immunity is still under evaluation, the currently licensed vaccines are extremely effective against severe disease, with vaccine efficacy significantly higher after the full immunization schedule. We investigate the impact of vaccines which have different efficacies after first dose and after the second dose administration schedule, eventually considering different efficacies against severe disease as opposed to overall infection. As a proof of concept, we model the vaccine performance of hospitalization reduction at the momentary scenario of the Basque Country, Spain, with population in a mixed vaccination setting, giving insights into the population coverage needed to achieve herd immunity in the current vaccination context.
What problem does this paper attempt to address?